Literature DB >> 30861078

Is Precision Medicine Consistent With Primary Care?

Dana E King1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30861078      PMCID： PMC6543827          DOI： 10.22454/FamMed.2019.687886

Source DB:  PubMed          Journal:  Fam Med        ISSN： 0742-3225            Impact factor:   1.756


× No keyword cloud information.
  9 in total

Review 1.  Asthma: personalized and precision medicine.

Authors:  Giorgio W Canonica; Matteo Ferrando; Ilaria Baiardini; Francesca Puggioni; Francesca Racca; Giovanni Passalacqua; Enrico Heffler
Journal:  Curr Opin Allergy Clin Immunol       Date:  2018-02

Review 2.  Implementing Precision Medicine: The Ethical Challenges.

Authors:  Diane M Korngiebel; Kenneth E Thummel; Wylie Burke
Journal:  Trends Pharmacol Sci       Date:  2016-12-07       Impact factor: 14.819

3.  Economic evaluation of a pharmacogenomic multi-gene panel test to optimize anti-hypertension therapy: simulation study.

Authors:  Eli F Kelley; Eric M Snyder; Nimer S Alkhatib; Scott C Snyder; Ryan Sprissler; Thomas P Olson; Monica K Akre; Ivo Abraham
Journal:  J Med Econ       Date:  2018-10-22       Impact factor: 2.448

Review 4.  Long noncoding RNAs in the pathogenesis of diabetic kidney disease: implications for novel therapeutic strategies.

Authors:  Fatjon Leti; Evan Morrison; Johanna K DiStefano
Journal:  Per Med       Date:  2017-05-05       Impact factor: 2.512

Review 5.  Support of precision medicine through risk-stratification in autoimmune liver diseases - histology, scoring systems, and non-invasive markers.

Authors:  Lars Bossen; Alessio Gerussi; Vasiliki Lygoura; George F Mells; Marco Carbone; Pietro Invernizzi
Journal:  Autoimmun Rev       Date:  2018-07-11       Impact factor: 9.754

Review 6.  Overview of precision oncology trials: challenges and opportunities.

Authors:  Elena Fountzilas; Apostolia M Tsimberidou
Journal:  Expert Rev Clin Pharmacol       Date:  2018-08-10       Impact factor: 5.045

Review 7.  Toward the potential cure of leukemias in the next decade.

Authors:  Hagop M Kantarjian; Michael J Keating; Emil J Freireich
Journal:  Cancer       Date:  2018-10-06       Impact factor: 6.860

Review 8.  Pharmacogenetics and Personalized Medicine in Pain Management.

Authors:  Lynn R Webster; Inna Belfer
Journal:  Clin Lab Med       Date:  2016-06-22       Impact factor: 1.935

Review 9.  Immunotherapy combined with epidermal growth factor receptor-tyrosine kinase inhibitors in non-small-cell lung cancer treatment.

Authors:  Hongge Liang; Xiaoyan Liu; Mengzhao Wang
Journal:  Onco Targets Ther       Date:  2018-09-25       Impact factor: 4.147
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.